Specialty drugs are administered typically by clinicians, even when they are self administered by patients, they require supervision and monitoring. Many of the specialty drugs are not approved by insurance companies. When such drugs are prescribed, they require special authorization from insurance companies before a specialty pharmacy would dispense them.

Let us look at three such (expensive) specialty drugs.

Zolgensma is approved to treat spinal muscular atrophy, a rare childhood disorder that causes muscular erosion that can lead to lung infections and muscle weakness. It is a one-time curative therapy, and many children who have been treated with the drug now show no signs of the disease. Zolgensma costs over $2 million.

Zokinvy is a drug that cures Hutchinson-Gilford progeria syndrome, a rare genetic disease that causes premature aging. It is an expensive drug costing over $80,000 a month.

Danyelza is prescribed to patients to treat pediatric and adult patients with neuroblastoma in the bone or bone marrow. Neuroblastoma is a cancer that develops from immature nerve cells.

Patients to fill commonly prescribed medications can find savings by using the
discount cards and coupons from www.AffordableMeds.Org.